About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Radiation Therapy Can Be Made Less Toxic By Inhibition of Key Inflammatory Protein

by Tanya Thomas on September 5, 2009 at 8:22 AM
Font : A-A+

 Radiation Therapy Can Be Made Less Toxic By Inhibition of Key Inflammatory Protein

Researchers at the Kimmel Cancer Center at Jefferson have reason to believe that directly inhibiting the activity of a key protein mediator of inflammation showed reduced radiation toxicity in zebrafish embryos. They now hope the same would be of help to patients receiving radiation therapy.

Reporting in Molecular Cancer Therapeutics, the researchers found that inhibitors of NF-kappa B not only protected against radiation toxicity when given before exposure to treatment, but also lessened the radiation toxicity when given one to two hours post-exposure.

Advertisement

In the study, both NF-kappa B inhibitors and proteasome inhibitors were examined for their potential to alleviate the negative effects of radiation. However, the proteasome inhibitors tested, which included the FDA-approved bortezomib (Velcade), did not show the same effect. In fact, they actually exacerbated the harmful radiation effects.

"Although proteasome inhibitors demonstrate activity against NF-kappa B, they also target many other pathways," said Ulrich Rodeck, M.D., Ph.D., professor of Dermatology and Cutaneous Biology at Jefferson Medical College of Thomas Jefferson University. "We suspect that these agents may radiosensitize due to inhibition of these other targets."
Advertisement

This study was led by Dr. Rodeck and Adam Dicker, M.D., Ph.D., professor and interim chairman of the department Radiation Oncology at Jefferson.

"We started with the premise that NF-kappa B activity might be helpful in protecting cells against the harmful effects of radiation," Dr. Rodeck said. "We actually found quite the opposite - inhibiting the activity is an advantage that increased the survival in zebrafish and protected the individual organs from harmful effects of radiation."

According to Dr. Rodeck, the key is to downmodulate the NF-kappa B activity, rather than ablating it completely, as excessive NF-kappa B activation is potentially detrimental even in the absence of radiation therapy.

Drs. Rodeck and Dicker will be moving this research forward so that it may ultimately help individuals exposed to "dirty bombs," or cancer patients receiving radiation therapy. Their research team pioneered using zebrafish embryos as a vertebrate model system to investigate the effects of radiation therapy.



Source: Eurekalert
TAN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
Test Your Knowledge About Chromosomes?
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Radiotherapy X-Ray Hodgkins Lymphoma Non-Hodgkins Lymphoma Reiki and Pranic Healing Radiation Hazards Acute Radiation Syndrome Linear Accelerator (LINAC) Proton Beam Therapy for Cancer Treatment Radiosurgery 

Most Popular on Medindia

Nutam (400mg) (Piracetam) Accident and Trauma Care Pregnancy Confirmation Calculator Vent Forte (Theophylline) The Essence of Yoga Sinopril (2mg) (Lacidipine) Drug Side Effects Calculator Daily Calorie Requirements Turmeric Powder - Health Benefits, Uses & Side Effects Indian Medical Journals
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Radiation Therapy Can Be Made Less Toxic By Inhibition of Key Inflammatory Protein Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests